How Did We Get a COVID-19 Vaccine in Less Than 1 Year?
E. John Wherry, Elizabeth M. Jaffee, Nicholas J.H. Warren, Gypsyamber DʼSouza, Antoni Ribas
Abstract
The successful development of COVID-19 vaccines within an unprecedented short time needs to be followed by rapid vaccine uptake, in particular, in high-risk populations such as patients with cancer. It is important for the scientific research community and cancer physicians to convey the knowledge behind the COVID-19 vaccine development and contribute to build the required trust on their use.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineCancerVirologyFamily medicineInfectious disease (medical specialty)DiseaseOutbreakInternal medicineSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research Studies